
Ticlopid250 mg
Drug International Ltd.
Ticlopidine Hydrochloride is an antiplatelet medicine belonging to the thienopyridine class.
Ticlopidine Hydrochloride is an antiplatelet medicine belonging to the thienopyridine class. Because of its serious hematologic side-effect profile, it is generally reserved for patients who cannot tolerate or have failed other antiplatelet therapies (such as aspirin or clopidogrel).
Ticlopidine Hydrochloride is typically considered a second-line antiplatelet agent rather than a first-choice therapy, due to the availability of alternatives with a more favorable safety profile.
Dosing of Ticlopidine Hydrochloride should be individualized by a physician based on indication and patient tolerance. Regular blood monitoring is required (see Precautions and Warnings).
| Indication | Adult Dose | Notes |
|---|---|---|
| Reduction of thrombotic stroke risk | 250 mg orally twice daily | Take with food to reduce gastrointestinal upset. |
| Prevention of subacute stent thrombosis | 250 mg orally twice daily, in combination with aspirin | Usually continued for up to approximately 30 days post-stenting, as directed by the treating physician. |
Pediatric dosing has not been established (see Use in Special Populations). No well-established formal renal dose adjustment exists; hepatic impairment requires caution and is contraindicated if severe (see Contraindications).
Common side effects of Ticlopidine Hydrochloride include:
Serious but less common effects requiring immediate medical attention include severe neutropenia/agranulocytosis, thrombotic thrombocytopenic purpura (TTP), aplastic anemia, serious bleeding, and liver enzyme abnormalities (see Precautions and Warnings).
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.